229 related articles for article (PubMed ID: 35842118)
1. Carvedilol Achieves Higher Hemodynamic Response and Lower Rebleeding Rates Than Propranolol in Secondary Prophylaxis.
Jachs M; Hartl L; Simbrunner B; Bauer D; Paternostro R; Balcar L; Hofer B; Pfisterer N; Schwarz M; Scheiner B; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T
Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2318-2326.e7. PubMed ID: 35842118
[TBL] [Abstract][Full Text] [Related]
2. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
Reiberger T; Ulbrich G; Ferlitsch A; Payer BA; Schwabl P; Pinter M; Heinisch BB; Trauner M; Kramer L; Peck-Radosavljevic M;
Gut; 2013 Nov; 62(11):1634-41. PubMed ID: 23250049
[TBL] [Abstract][Full Text] [Related]
3. A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis.
Kim SG; Kim TY; Sohn JH; Um SH; Seo YS; Baik SK; Kim MY; Jang JY; Jeong SW; Lee B; Kim YS; Suk KT; Kim DJ
Am J Gastroenterol; 2016 Nov; 111(11):1582-1590. PubMed ID: 27575713
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic Effects of Adding Simvastatin to Carvedilol for Primary Prophylaxis of Variceal Bleeding: A Randomized Controlled Trial.
Vijayaraghavan R; Jindal A; Arora V; Choudhary A; Kumar G; Sarin SK
Am J Gastroenterol; 2020 May; 115(5):729-737. PubMed ID: 32079861
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic Response to Carvedilol is Maintained for Long Periods and Leads to Better Clinical Outcome in Cirrhosis: A Prospective Study.
Kirnake V; Arora A; Gupta V; Sharma P; Singla V; Bansal N; Goyal M; Chawlani R; Kumar A
J Clin Exp Hepatol; 2016 Sep; 6(3):175-185. PubMed ID: 27746613
[TBL] [Abstract][Full Text] [Related]
6. Carvedilol as the new non-selective beta-blocker of choice in patients with cirrhosis and portal hypertension.
Turco L; Reiberger T; Vitale G; La Mura V
Liver Int; 2023 Jun; 43(6):1183-1194. PubMed ID: 36897563
[TBL] [Abstract][Full Text] [Related]
7. Acute hemodynamic response to propranolol predicts bleeding and nonbleeding decompensation in patients with cirrhosis.
Hofer BS; Simbrunner B; Bauer DJM; Paternostro R; Schwabl P; Scheiner B; Semmler G; Hartl L; Jachs M; Datterl B; Staettermayer AF; Trauner M; Mandorfer M; Reiberger T
Hepatol Commun; 2022 Sep; 6(9):2569-2580. PubMed ID: 35808889
[TBL] [Abstract][Full Text] [Related]
8. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.
Sauerbruch T; Mengel M; Dollinger M; Zipprich A; Rössle M; Panther E; Wiest R; Caca K; Hoffmeister A; Lutz H; Schoo R; Lorenzen H; Trebicka J; Appenrodt B; Schepke M; Fimmers R;
Gastroenterology; 2015 Sep; 149(3):660-8.e1. PubMed ID: 25989386
[TBL] [Abstract][Full Text] [Related]
9. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
[TBL] [Abstract][Full Text] [Related]
10. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial.
Mishra SR; Chander Sharma B; Kumar A; Sarin SK
Gut; 2010 Jun; 59(6):729-35. PubMed ID: 20551457
[TBL] [Abstract][Full Text] [Related]
12. Comparison of carvedilol and propranolol for primary prophylaxis of esophageal variceal bleed in cirrhotic patients.
Muhammad Farooq Hanif -; Raja Omer Fiaz -; Muhammad Adnan Iqbal -; Aneeza Ilyas -; Maria -; Khalid Mahmud Khan -; Nooman Gilani -
Pak J Pharm Sci; 2023 May; 36(3):857-862. PubMed ID: 37580935
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic prevention of variceal bleeding and rebleeding.
Baiges A; Hernández-Gea V; Bosch J
Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
[TBL] [Abstract][Full Text] [Related]
14. Carvedilol versus propranolol effect on hepatic venous pressure gradient at 1 month in patients with index variceal bleed: RCT.
Gupta V; Rawat R; Shalimar ; Saraya A
Hepatol Int; 2017 Mar; 11(2):181-187. PubMed ID: 27624505
[TBL] [Abstract][Full Text] [Related]
15. Long-term Outcomes with Carvedilol versus Propranolol in Patients with Index Variceal Bleed: 6-year Follow-up Study.
Sharma S; Agarwal S; Gunjan D; Kaushal K; Anand A; Mohta S; Shalimar ; Saraya A
J Clin Exp Hepatol; 2021; 11(3):343-353. PubMed ID: 33994717
[TBL] [Abstract][Full Text] [Related]
16. Second prophylaxis of variceal bleeding in cirrhotic patients with a high HVPG.
Zhang M; Wang G; Zhao L; Wu Z; Zhang W; Zhang C
Scand J Gastroenterol; 2016 Dec; 51(12):1502-1506. PubMed ID: 27379704
[TBL] [Abstract][Full Text] [Related]
17. Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices.
Zacharias AP; Jeyaraj R; Hobolth L; Bendtsen F; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011510. PubMed ID: 30372514
[TBL] [Abstract][Full Text] [Related]
18. Carvedilol as secondary prophylaxis for variceal bleeding in hepatosplenic schistosomiasis.
de Abreu ES; Nardelli MJ; Lima AMC; Cardoso JB; Osório FMF; Ferrari TCA; Faria LC; Couto CA; Cançado GGL
Trans R Soc Trop Med Hyg; 2022 Jul; 116(7):663-667. PubMed ID: 35059714
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose-response study.
Schwarzer R; Kivaranovic D; Paternostro R; Mandorfer M; Reiberger T; Trauner M; Peck-Radosavljevic M; Ferlitsch A
Aliment Pharmacol Ther; 2018 Apr; 47(8):1162-1169. PubMed ID: 29492989
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices.
Paternostro R; Becker J; Hofer BS; Panagl V; Schiffke H; Simbrunner B; Semmler G; Schwabl P; Scheiner B; Bucsics T; Bauer D; Binter T; Trauner M; Mandorfer M; Reiberger T
Dig Liver Dis; 2022 Apr; 54(4):500-508. PubMed ID: 34799282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
